Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

High Pressure IC Speeds Separations of Counter Ions in a Drug Tablet

Published: Friday, April 19, 2013
Last Updated: Friday, April 19, 2013
Bookmark and Share
New technical note on rapid separation and quantification of counter ion using Dionex ICS-5000+ HPIC system.

Thermo Fisher Scientific has announced a new technical note on the rapid separation and quantification of a pharmaceutical counter ion using increased flow rates on our high-pressure capillary Ion Chromatography system, the Thermo Scientific Dionex ICS-5000+ HPIC system.

Technical Note 120: Fast Separations of Counter Ions in an Allergy Drug Tablet Using High-Pressure IC demonstrates the importance of counter ion determinations in order to confirm the correct stoichiometry and formula weight of a drug, and, also to test for drug impurities.

With the upgrade to high pressure, capillary systems can operate at system pressures up to 5000 psi.

This advance in technology allows 2X to 3X the µL/min flow rates with all the same advantages as standard pressure capillary IC, resulting in low consumption of water (30 to 40 mL/d of water) and low waste generation.

Capillary IC systems can remain on 24/7 with minimal resource consumption which translates into a system which has greater ease-of-use, a longer lasting eluent generator cartridge and a far more inexpensive cost of ownership associated with it.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Q3 Revenues up 31 Percent
Thermo Fisher announced that revenues grew 31% to $4.17 billion for the third quarter ended September 27, 2014.
Thursday, October 23, 2014
Thermo Reports 6% Q4 Revenue Growth
Thermo Fisher Scientific Inc. reported its financial results for the fourth quarter and full year ended December 31, 2013.
Friday, January 31, 2014
Record Revenues for Thermo Fisher Scientific
Revenue for the quarter grew 6% to $3.26 billion in 2012, versus $3.09 billion in 2011.
Thursday, January 31, 2013
Thermo Fisher Scientific Demonstrates Leadership in Food Safety at AOAC 2010
Highlights include Food Safety Response Center and complete workflow solutions.
Tuesday, September 28, 2010
Thermo Fisher Scientific Launches Maybridge Ro3 Diversity Fragment Library
Diverse set of 1,500 molecules engineered for high-quality fragment screening-based programmes.
Tuesday, July 06, 2010
Thermo Fisher Scientific Webinar Addresses Future Trace Elemental Analysis Requirements Using AA, ICP and ICP-MS
Webinar entitled "Preparing for Future Trends in Elemental Food Safety Analysis," is now available to view on-demand.
Thursday, May 13, 2010
Thermo Fisher Scientific Announces 2010 Food Safety Seminars in Europe
The seminars will provide an opportunity to learn about the latest advances from experts in the field and also from Thermo Fisher's food safety scientists.
Wednesday, April 28, 2010
Thermo Fisher Scientific Opens Global Food Safety Response Center
Designed to aid governments and businesses facing unknown food safety threats involving chemical contaminants.
Friday, April 16, 2010
Thermo Fisher Scientific and Cerilliant Corporation to Offer Certified Solution Standards for Forensic and Clinical Research Laboratories
Thermo Fisher Scientific Inc., today announced a joint agreement with Cerilliant Corporation to develop and manufacture certified solution standards for the Thermo Scientific ToxSpec Analyzer. Under the marketing agreement, Cerilliant will develop a number of ready-to-use certified solution standards for use with the ToxSpec Analyzer, a complete and easy-to-use LC/MS solution for drugs of abuse analysis in forensic and clinical research laboratories.
Wednesday, January 06, 2010
Thermo Fisher Scientific Presents Innovative Solutions in Food Safety at RAFA 2009
The Company will exhibit innovative food safety solutions at the 4th International RAFA Symposium from November 4-6, 2009.
Tuesday, November 03, 2009
Thermo Fisher Scientific and Symyx Technologies to Deliver Integrated LIMS and ELN Solutions to Scientists
Thermo Fisher Scientific Inc., today announced the release of a joint product development effort resulting from its partnership with Symyx Technologies.
Tuesday, October 27, 2009
Thermo Fisher Scientific qPCR Products help to Improve Sensitivity in Toxicogenomic Studies
Researchers at the University of Surrey, Guildford, UK are studying the changes in gene expression within cultured human cells that are exposed to drugs and toxicants. Gene expression is measured by isolating total RNA and quantifying mRNA from target genes within the cells.
Thursday, October 22, 2009
Thermo Fisher Scientific to Showcase Innovative Mass Spectrometry Solutions at IMSC 2009
Company will showcase a variety of mass spectrometry software and hardware solutions to deliver improved analytical performance.
Monday, September 07, 2009
Thermo Fisher Scientific Implements LIMS for the Food and Environment Research Agency
Fera uses Thermo Scientific Nautilus to manage critical laboratory data and processes.
Thursday, September 03, 2009
Thermo Fisher Scientific Goes Global with Food Safety Seminar Series
The global seminar program will take place across the U.S., Canada, Europe, Southeast Asia and Japan to explore global perspectives on food safety.
Friday, August 28, 2009
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!